Literature DB >> 23891335

One year follow-up of functional recovery in neovascular AMD during monthly anti-VEGF treatment.

Marion R Munk1, Christopher Kiss, Wolfgang Huf, Florian Sulzbacher, Philipp Roberts, Tamara J Mittermüller, Stefan Sacu, Christian Simader, Ursula Schmidt-Erfurth.   

Abstract

PURPOSE: To identify neurosensory recovery, testing different functional variables during monthly intravitreal standard anti-vascular endothelial growth factor (VEGF) therapy in neovascular age-related macular degeneration (AMD).
DESIGN: Prospective interventional cohort study.
METHODS: Sixty-four treatment-naïve neovascular AMD patients with subfoveal lesions were treated and examined monthly for distance visual acuity, reading acuity, maximum reading speed, and contrast sensitivity and with microperimetry evaluating the percentage of absolute and relative scotoma and mean central retinal sensitivity weighted by area. Improvements in reading acuity, distance acuity, reading speed, contrast sensitivity, mean central retinal sensitivity, and scotoma area in dependence of age, lesion type, lesion size, and mean central retinal sensitivity were evaluated by a random-slope and random-intercept model. Recovery pattern of parameters was compared by correlating the individual slopes of each variable.
RESULTS: Initially, a rapid short-term effect of anti-VEGF treatment was documented throughout all functional variables. Progressive functional gain over 1 year was observed for distance visual acuity (P = .011), contrast sensitivity (P ≤ .0001), and mean central retinal sensitivity (P ≤ .0001), but not for reading acuity (P = .31) and maximum reading speed (P = .94). Decrease of absolute scotoma area missed statistical significance over time (P = .053) and also fixation stability did not improve (P = .08). However, lesion size influenced the course of absolute scotoma area (P = .0015), while lesion type had no effect on any visual function variable evaluated. The individual slopes of reading acuity and distance visual acuity showed a moderate correlation; however, all other variables showed only a weak or no significant correlation among each other.
CONCLUSION: Visual recovery in anti-VEGF therapy is reflected in a characteristic pattern of functional changes over time, whereas distance visual acuity does not seem to comprehensively reflect overall visual function gain.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23891335     DOI: 10.1016/j.ajo.2013.05.037

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  15 in total

Review 1.  [Ophthalmologic reading charts : Part 2: Current logarithmically scaled reading charts].

Authors:  W Radner
Journal:  Ophthalmologe       Date:  2016-12       Impact factor: 1.059

2.  The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease.

Authors:  Richard L Sidman; Jianxue Li; Matthew Lawrence; Wenzheng Hu; Gary F Musso; Ricardo J Giordano; Marina Cardó-Vila; Renata Pasqualini; Wadih Arap
Journal:  Sci Transl Med       Date:  2015-10-14       Impact factor: 17.956

3.  Structures affecting recovery of macular function in patients with age-related macular degeneration after intravitreal ranibizumab.

Authors:  Tomoharu Nishimura; Shigeki Machida; Kouhei Hashizume; Daijiro Kurosaka
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-28       Impact factor: 3.117

4.  A new principle for the standardization of long paragraphs for reading speed analysis.

Authors:  Wolfgang Radner; Stephan Radner; Gabriela Diendorfer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-11-05       Impact factor: 3.117

Review 5.  Near vision examination in presbyopia patients: Do we need good homologated near vision charts?

Authors:  Wolfgang Radner
Journal:  Eye Vis (Lond)       Date:  2016-11-10

Review 6.  Reading charts in ophthalmology.

Authors:  W Radner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-14       Impact factor: 3.117

7.  THE OASIS MP-1 SUBSTUDY: Characterization of the Effect of Ocriplasmin on Microperimetry Parameters.

Authors:  SriniVas R Sadda; Pravin U Dugel; Victor H Gonzalez; Esmeralda Meunier; Petra Kozma
Journal:  Retina       Date:  2019-02       Impact factor: 4.256

Review 8.  Quantitative physiological measurements to evaluate the response of antivascular endothelial growth factor treatment in patients with neovascular diseases.

Authors:  In Hwan Hong; Sung Pyo Park
Journal:  Indian J Ophthalmol       Date:  2017-07       Impact factor: 1.848

9.  Foveal threshold and photoreceptor integrity for prediction of visual acuity after intravitreal aflibercept on age-related macular degeneration.

Authors:  Tsutomu Sakai; Sachiyo Okude; Hiroshi Tsuneoka
Journal:  Clin Ophthalmol       Date:  2018-04-16

10.  Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration.

Authors:  Maximilian Pfau; Soumya Sahu; Rawan Allozi Rupnow; Kathleen Romond; Desiree Millet; Frank G Holz; Steffen Schmitz-Valckenberg; Monika Fleckenstein; Jennifer I Lim; Luis de Sisternes; Theodore Leng; Daniel L Rubin; Joelle A Hallak
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.